002864 盘龙药业
已收盘 12-19 15:00:00
资讯
新帖
简况
国元证券:给予盘龙药业买入评级
证券之星 · 12-18 17:42
国元证券:给予盘龙药业买入评级
医药板块又爆了!医药商业“扛大旗”,行业将迎反转曙光?
格隆汇 · 12-12
医药板块又爆了!医药商业“扛大旗”,行业将迎反转曙光?
异动快报:盘龙药业(002864)12月12日10点12分触及涨停板
证券之星 · 12-12
异动快报:盘龙药业(002864)12月12日10点12分触及涨停板
A股中药板块短线拉升,精华制药封板涨停,金花股份、葫芦娃此前封板,粤万年青、盘龙药业、红日药业、万邦德、特一药业等跟涨。
美港电讯 · 11-26
A股中药板块短线拉升,精华制药封板涨停,金花股份、葫芦娃此前封板,粤万年青、盘龙药业、红日药业、万邦德、特一药业等跟涨。
盘龙药业荣获证券之星资本力量2024年度最具社会责任上市公司等三项大奖
证券之星 · 11-15
盘龙药业荣获证券之星资本力量2024年度最具社会责任上市公司等三项大奖
盘龙药业最新公告:前三季度净利润8957.17万元 同比增长6.50%
证券之星 · 10-27
盘龙药业最新公告:前三季度净利润8957.17万元 同比增长6.50%
盘龙药业(002864)9月30日股东户数2.42万户,较上期增加2.26%
证券之星 · 10-27
盘龙药业(002864)9月30日股东户数2.42万户,较上期增加2.26%
盘龙药业(002864.SZ)发布前三季度业绩,净利润8957.17万元,同比增长6.50%
智通财经 · 10-27
盘龙药业(002864.SZ)发布前三季度业绩,净利润8957.17万元,同比增长6.50%
盘龙药业:10月18日组织现场参观活动,东吴证券、长城证券等多家机构参与
证券之星 · 10-22
盘龙药业:10月18日组织现场参观活动,东吴证券、长城证券等多家机构参与
盘龙药业(002864)9月30日主力资金净卖出722.00万元
证券之星 · 09-30
盘龙药业(002864)9月30日主力资金净卖出722.00万元
华源证券:给予盘龙药业买入评级
证券之星 · 09-13
华源证券:给予盘龙药业买入评级
【机构调研记录】天弘基金调研安井食品、盘龙药业
证券之星 · 09-11
【机构调研记录】天弘基金调研安井食品、盘龙药业
【机构调研记录】华商基金调研盘龙药业
证券之星 · 09-11
【机构调研记录】华商基金调研盘龙药业
【私募调研记录】玖歌投资调研盘龙药业
证券之星 · 09-11
【私募调研记录】玖歌投资调研盘龙药业
盘龙药业:公司将在定期报告中披露对应时点的股东人数,请关注公司定期报告
证券之星 · 09-03
盘龙药业:公司将在定期报告中披露对应时点的股东人数,请关注公司定期报告
盘龙药业最新公告:上半年净利润5965.33万元 同比增长9.95%
证券之星 · 08-27
盘龙药业最新公告:上半年净利润5965.33万元 同比增长9.95%
盘龙药业(002864.SZ)发布上半年业绩,净利润5965.33万元,增长9.95%
智通财经 · 08-27
盘龙药业(002864.SZ)发布上半年业绩,净利润5965.33万元,增长9.95%
盘龙药业:公司目前暂无治疗猴痘相关药物
证券之星 · 08-19
盘龙药业:公司目前暂无治疗猴痘相关药物
盘龙药业:关于高级管理人员辞职的公告
智能小浪 · 08-15
盘龙药业:关于高级管理人员辞职的公告
盘龙药业:公司将在定期报告中披露对应时点的股东人数,请关注公司定期报告
证券之星 · 08-12
盘龙药业:公司将在定期报告中披露对应时点的股东人数,请关注公司定期报告
加载更多
公司概况
公司名称:
陕西盘龙药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2017-11-16
主营业务:
陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售及医药物流。公司主要产品包括盘龙七片、白芍总苷胶囊、痹祺胶囊、尪痹胶囊、尪痹片、盘龙七药酒、骨松宝片、金茵利胆胶囊、克比热提片、复方醋酸棉酚片、益母草颗粒、参苓白术散、小儿麦枣咀嚼片、小儿咽扁颗粒、公司大健康产品。公司被评为“国家企业技术中心”。2020年6月6日公司的独家品种盘龙七片被评选为首届陕西“秦药”优势中成药品种,盘龙七片处方中的盘龙七药材被评为陕西“秦药”区域特色中草药,进一步提升了公司盘龙品牌。
发行价格:
10.03
{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":31.83,"timestamp":1734591816000,"preClose":31.48,"halted":0,"volume":7221872,"delay":0,"floatShares":73984600,"shares":106000000,"eps":1.0906,"marketStatus":"已收盘","marketStatusCode":5,"change":0.35,"latestTime":"12-19 15:00:00","open":31.49,"high":32.65,"low":31.35,"amount":231000000,"amplitude":0.0413,"askPrice":31.84,"askSize":81,"bidPrice":31.83,"bidSize":186,"shortable":0,"etf":0,"ttmEps":1.0906,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":31.48,"symbolType":"stock","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":34.63,"lowLimit":28.33,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":106280960,"pbRate":2.08,"roa":"--","roe":"5.66%","epsLYR":1.15,"committee":0.52924,"marketValue":3383000000,"floatMarketCap":2355000000,"peRate":29.185769,"changeRate":0.0111,"turnoverRate":0.0976,"status":0},"requestUrl":"/m/hq/s/002864","defaultTab":"news","newsList":[{"id":"2492797046","title":"国元证券:给予盘龙药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492797046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492797046?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:42","pubTimestamp":1734514940,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司马云涛近期对盘龙药业进行研究并发布了研究报告《首次覆盖报告:盘龙七片引领发展,一体两翼战略初现成效》,本报告对盘龙药业给出买入评级,当前股价为31.48元。公司核心产品盘龙七片稳健增长,未来有望进入基药目录后实现进一步放量。首次覆盖,给予“买入”评级。最新盈利预测明细如下:该股最近90天内共有1家机构给出评级,买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800030046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000728","002864"],"gpt_icon":0},{"id":"2490828727","title":"医药板块又爆了!医药商业“扛大旗”,行业将迎反转曙光?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490828727","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490828727?lang=zh_cn&edition=full","pubTime":"2024-12-12 11:42","pubTimestamp":1733974975,"startTime":"0","endTime":"0","summary":"开开实业、人民同泰领涨","market":"hk","thumbnail":"https://img3.gelonghui.com/0433a-af80b551-80b3-4ce3-8959-228f2e481322.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/0433a-af80b551-80b3-4ce3-8959-228f2e481322.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1468831","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["600829","BK0209","BK0097","603716","BK0224","BK0188","603883","BK1515","BK0060","301408","600272","300937","BK0250","301017","BK0239","BK1574","BK0099","BK0184","09939","BK0077","BK1161","600422","BK0028","002864","300391","BK0086","600833"],"gpt_icon":0},{"id":"2490449178","title":"异动快报:盘龙药业(002864)12月12日10点12分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2490449178","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490449178?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:15","pubTimestamp":1733969724,"startTime":"0","endTime":"0","summary":"证券之星12月12日盘中消息,10点12分盘龙药业(002864)触及涨停板。目前价格31.56,上涨10.0%。其所属行业中药目前上涨。领涨股为昆药集团。该股为食品,保健品,中药概念热股,当日食品概念上涨1.59%,保健品概念上涨0.99%,中药概念上涨0.77%。12月11日的资金流向数据方面,主力资金净流出530.08万元,占总成交额11.04%,游资资金净流出53.82万元,占总成交额1.12%,散户资金净流入583.9万元,占总成交额12.17%。近5日资金流向一览见下表:盘龙药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200011031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2486912013","title":"A股中药板块短线拉升,精华制药封板涨停,金花股份、葫芦娃此前封板,粤万年青、盘龙药业、红日药业、万邦德、特一药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2486912013","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486912013?lang=zh_cn&edition=full","pubTime":"2024-11-26 11:10","pubTimestamp":1732590630,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0102","600080","BK0188","002349","BK0201","002082","BK0004","159982","BK0077","300026","605199","002728","BK0050","399300","301111","BK0239","002864","BK0028"],"gpt_icon":0},{"id":"2483162243","title":"盘龙药业荣获证券之星资本力量2024年度最具社会责任上市公司等三项大奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2483162243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483162243?lang=zh_cn&edition=full","pubTime":"2024-11-15 14:33","pubTimestamp":1731652436,"startTime":"0","endTime":"0","summary":"同时,盘龙药业还高度重视品牌影响力的提升。正是这些努力,让盘龙药业在激烈的市场竞争中脱颖而出,成为了中药行业的佼佼者。此次荣获最具社会责任上市公司奖,是对盘龙药业多年来履行社会责任和助力高质量发展得认可和肯定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024111500018096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","161027","002864","161912"],"gpt_icon":0},{"id":"2478544111","title":"盘龙药业最新公告:前三季度净利润8957.17万元 同比增长6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478544111","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478544111?lang=zh_cn&edition=full","pubTime":"2024-10-27 19:40","pubTimestamp":1730029202,"startTime":"0","endTime":"0","summary":"盘龙药业发布2024年第三季度报告,前三季度实现营业收入7.17亿元,同比增长0.10%;净利润8957.17万元,同比增长6.50%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700014097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"gpt_icon":0},{"id":"2478158667","title":"盘龙药业(002864)9月30日股东户数2.42万户,较上期增加2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478158667","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478158667?lang=zh_cn&edition=full","pubTime":"2024-10-27 17:01","pubTimestamp":1730019674,"startTime":"0","endTime":"0","summary":"证券之星消息,近日盘龙药业披露,截至2024年9月30日公司股东户数为2.42万户,较6月30日增加536.0户,增幅为2.26%。在中药行业个股中,盘龙药业股东户数低于行业平均水平,截至9月30日,中药行业平均股东户数为4.97万户。从股价来看,2024年6月30日至2024年9月30日,盘龙药业区间涨幅为7.69%,在此期间股东户数增加536.0户,增幅为2.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700013071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2478378681","title":"盘龙药业(002864.SZ)发布前三季度业绩,净利润8957.17万元,同比增长6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478378681","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478378681?lang=zh_cn&edition=full","pubTime":"2024-10-27 16:16","pubTimestamp":1730017015,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盘龙药业(002864.SZ)发布2024年三季度报告,前三季度,公司实现营业收入7.17亿元,同比增长0.10%。归属于上市公司股东的净利润8957.17万元,同比增长6.50%。归属于上市公司股东的扣除非经常性损益的净利润8059.21万元,同比下降5.80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002864"],"gpt_icon":0},{"id":"2477450878","title":"盘龙药业:10月18日组织现场参观活动,东吴证券、长城证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2477450878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477450878?lang=zh_cn&edition=full","pubTime":"2024-10-22 12:02","pubTimestamp":1729569748,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年10月21日盘龙药业发布公告称公司于2024年10月18日组织现场参观活动,东吴证券、长城证券、天风证券、时代伯乐、海南墨竹基金、深圳林园投资、招商基金、投资者、华源证券、银河证券、中泰证券、湘财证券、国元证券、浙商证券、申万宏源、海通证券参与。目前,中药行业已步入第三批集采,公司核心产品此次未被纳入集采目录。该股最近90天内共有1家机构给出评级,买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200016251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","BK0188","BK0276","BK0009","BK0239","002939","002864","BK0183","BK0028","BK0012"],"gpt_icon":0},{"id":"2471824309","title":"盘龙药业(002864)9月30日主力资金净卖出722.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471824309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471824309?lang=zh_cn&edition=full","pubTime":"2024-09-30 15:31","pubTimestamp":1727681482,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月30日收盘,盘龙药业报收于27.87元,上涨7.61%,换手率10.41%,成交量7.79万手,成交额2.13亿元。9月30日的资金流向数据方面,主力资金净流出722.0万元,占总成交额3.39%,游资资金净流入1536.44万元,占总成交额7.22%,散户资金净流出814.43万元,占总成交额3.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000022001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2467773696","title":"华源证券:给予盘龙药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2467773696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467773696?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:30","pubTimestamp":1726234234,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯近期对盘龙药业进行研究并发布了研究报告《聚焦风湿骨病,核心品种盘龙七片增长弹性十足》,本报告对盘龙药业给出买入评级,当前股价为23.03元。公司核心产品盘龙七片市场份额领先,未来有望进入基药,增长空间弹性十足,首次覆盖,给予“买入”评级。医药行业政策风险,产品降价风险,主要原材料价格波动的风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091300042924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","161027"],"gpt_icon":0},{"id":"2466115764","title":"【机构调研记录】天弘基金调研安井食品、盘龙药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2466115764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466115764?lang=zh_cn&edition=full","pubTime":"2024-09-11 08:01","pubTimestamp":1726012895,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及9月10日披露的机构调研信息,天弘基金近期对2家上市公司进行了调研,相关名单如下:1)安井食品 个股亮点:公司速冻菜肴有酥肉、梅菜扣肉、佛跳墙等家喻户晓的预制菜;公司位于福建省厦门市海沧区新阳路2508号,主营火锅料制品、速冻面米制品等速冻食品的研发、生产和销售2)盘龙药业 个股亮点:公司积极推动中药新药研发等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100007782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245177.USD","BK0201","002864","BK0238","BK0239","LU1997245094.SGD","603345"],"gpt_icon":0},{"id":"2466411654","title":"【机构调研记录】华商基金调研盘龙药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2466411654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466411654?lang=zh_cn&edition=full","pubTime":"2024-09-11 08:01","pubTimestamp":1726012877,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及9月10日披露的机构调研信息,华商基金近期对1家上市公司进行了调研,相关名单如下:1)盘龙药业 个股亮点:公司积极推动中药新药研发等。华商基金成立于2005年,截至目前,资产管理规模1350.0亿元,排名50/207;资产管理规模1137.66亿元,排名45/207;管理公募基金数146只,排名46/207;旗下公募基金经理24人,排名55/207。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100007763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2466341168","title":"【私募调研记录】玖歌投资调研盘龙药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2466341168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466341168?lang=zh_cn&edition=full","pubTime":"2024-09-11 08:01","pubTimestamp":1726012862,"startTime":"0","endTime":"0","summary":"根据市场公开信息及9月10日披露的机构调研信息,知名私募玖歌投资近期对1家上市公司进行了调研,相关名单如下:1)盘龙药业 个股亮点:公司积极推动中药新药研发等。玖歌投资于2014年4月获得中国证券投资基金协会颁发的证券投资基金管理人资格。玖歌投资多年坚持价值投资理念,公司历经多轮牛熊考验,追求稳健成长。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2024091100007745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2464987328","title":"盘龙药业:公司将在定期报告中披露对应时点的股东人数,请关注公司定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2464987328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464987328?lang=zh_cn&edition=full","pubTime":"2024-09-03 18:04","pubTimestamp":1725357858,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业(002864)09月03日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘: 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2024年8月30日股东人数是多少?谢谢盘龙药业董秘:尊敬的投资者您好!公司将在定期报告中披露对应时点的股东人数,请关注公司定期报告。感谢您的关注!以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300030300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2462918681","title":"盘龙药业最新公告:上半年净利润5965.33万元 同比增长9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462918681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462918681?lang=zh_cn&edition=full","pubTime":"2024-08-27 22:31","pubTimestamp":1724769082,"startTime":"0","endTime":"0","summary":"盘龙药业公布2024年半年度报告,报告期营业收入4.55亿元,同比下降8.93%;归属于上市公司股东的净利润5965.33万元,同比增长9.95%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700041295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"gpt_icon":0},{"id":"2462716651","title":"盘龙药业(002864.SZ)发布上半年业绩,净利润5965.33万元,增长9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462716651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462716651?lang=zh_cn&edition=full","pubTime":"2024-08-27 19:40","pubTimestamp":1724758802,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盘龙药业(002864.SZ)发布2024年半年度报告,报告期内,公司实现营业收入4.55亿元,同比下降8.93%。实现归属于上市公司股东的净利润5965.33万元,同比增长9.95%。实现归属于上市公司股东的扣除非经常性损益的净利润5073.41万元,同比下降1.10%。基本每股收益0.57元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1172123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002864"],"gpt_icon":0},{"id":"2460408616","title":"盘龙药业:公司目前暂无治疗猴痘相关药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2460408616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460408616?lang=zh_cn&edition=full","pubTime":"2024-08-19 18:02","pubTimestamp":1724061730,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业(002864)08月19日在投资者关系平台上答复投资者关心的问题。投资者:请问贵公司有没有可以治疗猴痘的药物出售?盘龙药业董秘:尊敬的投资者您好!公司目前暂无治疗猴痘相关药物。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081900024698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2459442383","title":"盘龙药业:关于高级管理人员辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2459442383","media":"智能小浪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459442383?lang=zh_cn&edition=full","pubTime":"2024-08-15 18:40","pubTimestamp":1723718400,"startTime":"0","endTime":"0","summary":"陕西盘龙药业集团股份有限公司关于高级管理人员辞职的公告本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。陕西盘龙药业集团股份有限公司董事会于近日收到公司总裁胡奇飞先生递交的书面辞职报告,胡奇飞先生因个人原因辞去公司总裁职务。不存在应当履行而未履行的股份锁定承诺事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-08-15/doc-incitnse6620038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2458606950","title":"盘龙药业:公司将在定期报告中披露对应时点的股东人数,请关注公司定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2458606950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458606950?lang=zh_cn&edition=full","pubTime":"2024-08-12 19:01","pubTimestamp":1723460510,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业08月12日在投资者关系平台上答复投资者关心的问题。谢谢盘龙药业董秘:尊敬的投资者您好!公司将在定期报告中披露对应时点的股东人数,请关注公司定期报告。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200025487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","stockEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.1499},{"period":"3month","weight":0.3967},{"period":"6month","weight":0.1957},{"period":"1year","weight":-0.1646},{"period":"ytd","weight":-0.1668}],"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","perCapita":"3056股","boardName":"医药制造业","registeredCapital":"10628万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售及医药物流。公司主要产品包括盘龙七片、白芍总苷胶囊、痹祺胶囊、尪痹胶囊、尪痹片、盘龙七药酒、骨松宝片、金茵利胆胶囊、克比热提片、复方醋酸棉酚片、益母草颗粒、参苓白术散、小儿麦枣咀嚼片、小儿咽扁颗粒、公司大健康产品。公司被评为“国家企业技术中心”。2020年6月6日公司的独家品种盘龙七片被评选为首届陕西“秦药”优势中成药品种,盘龙七片处方中的盘龙七药材被评为陕西“秦药”区域特色中草药,进一步提升了公司盘龙品牌。","serverTime":1734632990075,"listedPrice":10.03,"stockholders":"24202人(较上一季度增加2.26%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}